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Background/Introduction
Controversy exists regarding the pathogenesis of bicus-
pid aortic valve (BAV) associated aortopathy. Recent
data indicate the potential role of lipid metabolism in
the expression of aortopathy.
Aims/Objectives
We aimed to correlate the markers of lipid metabolism
with severity of proximal aortopathy in patients with
BAV vs. tricuspid aortic valve (TAV) disease.
Method
A total of 458 consecutive patients (mean age 64 ± 11
years, 68% male) underwent aortic valve replacement
(AVR) with/without proximal aortic surgery from Janu-
ary,2008 through December,2014. All patients under-
going combined procedures (e.g., AVR+CABG) were
excluded. Only patients in whom proximal aortic dimen-
sions were defined by preoperative CT/MRI and/or TOE
were included. Correlation analysis was performed
between markers of lipid metabolism (i.e., cholesterol,
LDL, HDL, and triglyceride) and maximal diameter of
the proximal aorta in BAV subgroup (n = 273) vs. TAV
subgroup (n = 185). Moreover, we compared correlation
patterns between markers of lipid metabolism and maxi-
mal aortic diameter in BAV insufficiency (n = 46) vs.
BAV stenosis (n = 227) cohorts. Logistic regression was
performed to identify risk factors for proximal aortic dia-
meter >40 mm in BAV and TAV subgroups.
Results
No correlation was found between markers of lipid meta-
bolism and proximal aortic diameter in BAV subgroup
(r = -0.1, p = 0.1) and TAV subgroup (r = 0.006, p = 0.9).
No significant differences in correlation patterns were
found between markers of lipid metabolism and maximal
aortic diameter in BAV insufficiency (r = 0.03, p = 0.8)
vs. BAV stenosis (r = -0.1, p = 0.1) cohorts. Logistic
regression analysis revealed triglyceride levels (HR 1.4,
p = 0.05) and statin therapy (HR 0.4, p = 0.03) as predic-
tors of proximal aortic diameter >40 mm in TAV sub-
group only.
Discussion/Conclusion
Our study demonstrates no linear correlation between
markers of lipid metabolism and proximal aortic dia-
meters in a surgical cohort of BAV and TAV patients.
Statin therapy and triglyceride levels influence signifi-
cantly proximal aortic diameter in patients with TAV,
but not with BAV disease.
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